The largest database of trusted experimental protocols

Vaborbactam

Manufactured by MedChemExpress

Vaborbactam is a laboratory product manufactured by MedChemExpress. It functions as a beta-lactamase inhibitor, designed to restore the efficacy of certain antibiotics against resistant bacterial strains.

Automatically generated - may contain errors

3 protocols using vaborbactam

1

Antimicrobial Combination Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Piperacillin, clavulanic acid, and tazobactam were purchased from Sigma-Aldrich. Avibactam was obtained from Advanced Chemblocks. Enmetazobactam, vaborbactam, and relebactam were acquired from MedChemExpress.
+ Open protocol
+ Expand
2

Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing was performed by reference broth microdilution methods conducted according to Clinical and Laboratory Standards Institute (CLSI) procedures [14 ]. Quality control testing was performed daily to ensure proper test conditions. Quality control strains included E coli ATCC 25922 and NCTC 13353, K pneumoniae ATCC 700603, ATCC BAA-1705 and BAA-2814, and Pseudomonas aeruginosa ATCC 27853. CLSI guidelines were used for the interpretation of susceptibility rates, with the exception of tigecycline, for which US Food and Drug Administration (FDA) breakpoints were applied [15 , 16 ]. Avibactam was provided by Allergan. Other agents were acquired from Sigma-Aldrich (St Louis, Missouri), US Pharmacopeia (Rockville, Maryland), Advanced Chemblocks (Hayward, California; relebactam), or MedChemExpress (Monmouth Junction, New Jersey; vaborbactam).
+ Open protocol
+ Expand
3

Carbapenemase-producing Klebsiella Resistance Mechanism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals were from Sigma and growth media from Oxoid, unless otherwise stated.
Meropenem was from Sequoia Research Products, vaborbactam and avibactam were from MedChemExpress. Strains used were K. pneumoniae Ecl8 (31) the TEM-1-producing ramR mutant (Arg44FS) clinical isolate KP21, the wild-type clinical isolate KP47 and the in vitroselected Ecl8-derived oqxR (Tyr109STOP) or ramR (Thr124Pro) loss-of-function mutants (29) . A plasmid carrying bla OXA-232 (pOXA-232) was recovered from K. pneumoniae clinical isolate KP11 (29) using a Qiagen plasmid purification kit, with the plasmid then used to transform E. coli DH5α to reduced piperacillin/tazobactam susceptibility (8 µg.mL -1 piperacillin and 4 µg.mL -1 tazobactam) using electroporation. Recombinants were confirmed to be cefotaxime susceptible before the plasmid was re-purified and used to transform K.
pneumoniae isolates. The bla OXA-232 -encoding region was confirmed as being unchanged from the original using PCR sequencing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!